Skip to content
  • Home
  • Book Bag: 0 items (Full)
    • English
    • 日本語
    • 中文(简体)
    • 中文(繁體)
    • اللغة العربية
  • About
Advanced
  • Myelodysplastic syndrome with...
  • Cite this
  • Text this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Add to Book Bag Remove from Book Bag
  • Permanent link

Myelodysplastic syndrome with concomitant <i>SF3B1</i> mutation and deletion of chromosome 5 long arm: outcomes and response to treatment

Not available.

Bibliographic Details
Published in:Haematologica
Main Authors: Rami Komrokji, Zaker Schwabkey, Zena Komrokji, Najla Al Ali, Luis Aguirre, Maximilian Stahl, Somedeb Ball, Emily Mason, Michael Savona, Valeria Santini, Angela Consagra, Uwe Platzbecker, Anne Sophie Kubasch, Yazan Madanat, Pierre Fenaux, Lin-Pierre Zhao, Mikkael A. Sekeres, Namrata Chandhok, Matteo Della Porta, Luca Lanino, Amy DeZern, David Sallman, Eric Padron, Zhuoer Xie, Koji Sasaki, Kensuke Takaoka, Akhil Jain, Monica Del Rey Gonzalez, Maria Diez Campelo, Guillermo Garcia-Manero
Format: Article
Language:English
Published: Ferrata Storti Foundation 2026-05-01
Online Access:https://haematologica.org/article/view/14161
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://haematologica.org/article/view/14161

Similar Items

  • Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia
    by: Brian Ball, et al.
    Published: (2018-08-01)
  • PB2014: A PHASE 2/3 TRIAL OF ORAL AZACITIDINE IN PATIENTS WITH LOW- OR INTERMEDIATE-RISK MYELODYSPLASTIC SYNDROMES
    by: Guillermo Garcia-Manero, et al.
    Published: (2023-08-01)
  • Association between treatment-emergent cytopenias and clinical responses to imetelstat in lower-risk myelodysplastic syndromes
    by: Amer M. Zeidan, et al.
    Published: (2026-04-01)
  • Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
    by: Namrata S. Chandhok, et al.
    Published: (2025-08-01)
  • S165: CONTINUOUS TRANFUSION INDEPENDENCE WITH IMETELSTAT IN HEAVILY TRANSFUSED NON-DEL(5Q) LOWER-RISK MYELODYSPLASTIC SYNDROMES RELAPSED/REFRACTORY TO ERYTHROPOIESIS STIMULATING AGENTS IN IMERGE PHASE 3
    by: Uwe Platzbecker, et al.
    Published: (2023-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs